Nano-X Imaging Ltd. (NNOX)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 19
in 70 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Nano-X Imaging’s second fiscal quarter of 2026 missed expectations on both the top and bottom line, as results reported September 9, 2026 showed EPS of -$0.79 trailed the -$0.16 estimate by -$0.63 while revenue of $4.2 million trailed the $5.4 million consensus (-23%). Revenue rose 36.7% to about $4.2 million, up from about $3.0 million a year ago, alongside continued investment across its imaging hardware and cloud software ecosystem that includes the Nanox.ARC platform and related services such as Nanox.CLOUD and Nanox.MARKETPLACE. Profitability remained pressured, with operating income of roughly -$55.5 million, matching net income of roughly -$55.5 million, compared with a net loss of about -$14.7 million a year ago (net income YoY -276.9%). The wider loss also flowed through to per-share results, with EPS down 276.2% from -$0.21 a year ago. For the next period, consensus calls for EPS of -$0.14 on revenue of $7.3 million.
About Nano-X Imaging Ltd.
Nano-X Imaging Ltd. develops medical imaging technology and related software for the healthcare market, trading on the NASDAQ Global Market as NNOX. The company combines imaging hardware, cloud software, marketplace and interpretation services, and generated $13.0 million of revenue in FY2025.
Today's Snapshot
NNOX is trading 6.4% lower at 0.73, in line with a weaker sector.
Trading Volume
Below 10d avg (2.1M)
1M
vs S&P 500 Today
Strong Underperformance
-5.80%
Updated: September 10, 2026 at 19:28 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$0.81 - $2.07Sell
- RSI (14)38.48Neutral
- Stochastic %K (14, 3, 3)49.35Neutral
- MACD Level (12, 26)-0.07Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.